{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:07:05Z","timestamp":1780405625102,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00292-011-1475-6","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T14:14:02Z","timestamp":1313590442000},"page":"461-466","source":"Crossref","is-referenced-by-count":8,"title":["Molekulare Diagnostik der HPV-Infektion","Molecular diagnosis of HPV infections"],"prefix":"10.1007","volume":"32","author":[{"given":"N.","family":"Wentzensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2007\/147429","volume":"23","author":"Brink","year":"2007","unstructured":"Brink AA, Snijders PJ, Meijer CJ (2007) HPV detection methods. Dis Markers 23:273\u2013281","journal-title":"Dis Markers"},{"key":"1475_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2010.11.013","volume":"120","author":"Burger","year":"2011","unstructured":"Burger EA, Kornor H, Klemp M et al (2011) HPV mRNA tests for the detection of cervical intr\u00e4pithelial neoplasia: a systematic review. Gynecol Oncol 120:430\u2013438","journal-title":"Gynecol Oncol"},{"key":"1475_CR3","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","volume":"46","author":"Castle","year":"2008","unstructured":"Castle PE, Solomon D, Wheeler CM et al (2008) Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 46:2595\u20132604","journal-title":"J Clin Microbiol"},{"key":"1475_CR4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","volume":"6","author":"Cogliano","year":"2005","unstructured":"Cogliano V, Baan R, Straif K et al (2005) Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204","journal-title":"Lancet Oncol"},{"key":"1475_CR5","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","volume":"17","author":"Cuschieri","year":"2008","unstructured":"Cuschieri K, Wentzensen N (2008) Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 17:2536\u20132545","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1475_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1155\/2007\/613150","volume":"23","author":"Doorbar","year":"2007","unstructured":"Doorbar J (2007) Papillomavirus life cycle organization and biomarker selection. Dis Markers 23:297\u2013313","journal-title":"Dis Markers"},{"key":"1475_CR7","first-page":"7075","volume":"62","author":"D\u00fcnsing","year":"2002","unstructured":"D\u00fcnsing S, Munger K (2002) The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62:7075\u20137082","journal-title":"Cancer Res"},{"key":"1475_CR8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA et al (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34:1077\u20131087","journal-title":"Am J Surg Pathol"},{"key":"1475_CR9","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/ijc.23012","volume":"121","author":"Gravitt","year":"2007","unstructured":"Gravitt PE, Kovacic MB, Herrero R et al (2007) High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787\u20132793","journal-title":"Int J Cancer"},{"key":"1475_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","volume":"134","author":"Kinney","year":"2011","unstructured":"Kinney W, Stoler MH, Castle PE (2011) Special commentary: patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 134:193\u2013199","journal-title":"Am J Clin Pathol"},{"key":"1475_CR11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R et al (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 128:927\u2013935","journal-title":"Int J Cancer"},{"key":"1475_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"McCredie","year":"2008","unstructured":"McCredie MR, Sharples KJ, Paul C et al (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intr\u00e4pithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425\u2013434","journal-title":"Lancet Oncol"},{"key":"1475_CR13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE et al (2009) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 yrs and older. Int J Cancer 124:516\u2013520","journal-title":"Int J Cancer"},{"key":"1475_CR14","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jcv.2004.12.004","volume":"32","author":"Molijn","year":"2005","unstructured":"Molijn A, Kleter B, Quint W, Doorn LJ van (2005) Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32(Suppl 1):S43\u2013S51","journal-title":"J Clin Virol"},{"key":"1475_CR15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24(Suppl 3):S3\/11\u2013 25","journal-title":"Vaccine"},{"key":"1475_CR16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"1475_CR17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jnci\/dji014","volume":"97","author":"Schiffman","year":"2005","unstructured":"Schiffman M, Khan MJ, Solomon D et al (2005) A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 97:147\u2013150","journal-title":"J Natl Cancer Inst"},{"key":"1475_CR18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","volume":"9","author":"Schiffman","year":"2008","unstructured":"Schiffman M, Rodriguez AC (2008) Heterogeneity in CIN3 diagnosis. Lancet Oncol 9:404\u2013406","journal-title":"Lancet Oncol"},{"key":"1475_CR19","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","volume":"70","author":"Schiffman","year":"2010","unstructured":"Schiffman M, Rodriguez AC, Chen Z et al (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159\u20133169","journal-title":"Cancer Res"},{"key":"1475_CR20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"Schiffman","year":"2011","unstructured":"Schiffman M, Wentzensen N, Wacholder S et al (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:368\u2013383","journal-title":"J Natl Cancer Inst"},{"key":"1475_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jmv.21719","volume":"82","author":"Schopp","year":"2010","unstructured":"Schopp B, Holz B, Zago M et al (2010) Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test. J Med Virol 82:605\u2013615","journal-title":"J Med Virol"},{"key":"1475_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","volume":"135","author":"Stoler","year":"2011","unstructured":"Stoler MH, Wright TC Jr, Sharma A et al (2011) High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 135:468\u2013475","journal-title":"Am J Clin Pathol"},{"key":"1475_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"1475_CR24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1055-9965.EPI-08-1180","volume":"18","author":"Wentzensen","year":"2009","unstructured":"Wentzensen N, Gravitt PE, Solomon D et al (2009) A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intr\u00e4pithelial lesion triage study. Cancer Epidemiol Biomarkers Prev 18:1341\u20131349","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1475_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","volume":"23","author":"Wentzensen","year":"2007","unstructured":"Wentzensen N, Knebel DM von (2007) Biomarkers in cervical cancer screening. Dis Markers 23:315\u2013330","journal-title":"Dis Markers"},{"key":"1475_CR26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","volume":"101","author":"Wheeler","year":"2009","unstructured":"Wheeler CM, Hunt WC, Joste NE et al (2009) Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101:475\u2013487","journal-title":"J Natl Cancer Inst"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-011-1475-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1475-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:01:08Z","timestamp":1559041268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-011-1475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s00292-011-1475-6","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}